Deepika Jalota insider trades: PMV Pharmaceuticals (PMVP) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Deepika reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 1, 2025 | PMVP | ↓ Sell | 33,065 | $1.06 | $35K | Direct | Jul 3, 2025 (2d) |
| Sep 11, 2024 | PMVP | ↓ Sell | 7,218 | $1.50 | $11K | Direct | Sep 12, 2024 (1d) |
| Sep 15, 2023 | PMVP | ↓ Sell | 4,104 | $6.62 | $27K | Direct | Sep 18, 2023 (3d) |
| Aug 17, 2021 | PMVP | ↓ Sell | 2,896 | $33.78 | $98K | Direct | Aug 18, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Deepika Jalota's insider trades
Deepika Jalota is Chief Development Officer at PMV Pharmaceuticals (PMVP). Since Aug 17, 2021, Deepika has reported no open-market purchases and 4 sales worth $171K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (8 filings), shares returned to the company (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PMVP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.